Publication: A study on CNS-side effects of mequitazine, an H<inf>1</inf>-specific antihistamine in healthy thai volunteers
Issued Date
1990-01-01
Resource Type
ISSN
0125877X
Other identifier(s)
2-s2.0-0025175528
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Allergy and Immunology. Vol.8, No.1 (1990), 39-44
Suggested Citation
B. Dhorranintra, T. Sriprasong, S. Limsuvan, S. Klyprayong A study on CNS-side effects of mequitazine, an H<inf>1</inf>-specific antihistamine in healthy thai volunteers. Asian Pacific Journal of Allergy and Immunology. Vol.8, No.1 (1990), 39-44. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/15963
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A study on CNS-side effects of mequitazine, an H<inf>1</inf>-specific antihistamine in healthy thai volunteers
Author(s)
Other Contributor(s)
Abstract
Mequitazine is a potent, non-sedative, long-acting H 1 -specific antihistamine proven to be a better therapeutic drug than other conventional antihistamines. It is also reported by many authors that the drug produces less sedative or other depressive actions on the central nervous system than other antihistamines. In order to evaluate the advantage of this drug in Asian people, an assessment of side effects of mequitazine, in comparison with chlorpheniramine, on the central nervous system was done in 20 healthy Thai volunteers, 10 males and 10 females 23-39 years of age, using a double blind crossover placebo controlled trial. Various subjective tests: alertness scale rating, visual analogue scale rating as well as objective tests: card sorting, glassbead picking and estimation of reaction time, were performed. There were no significant differences in side effects on the central nervous system between mequitazine and the placebo, whereas chlorpheniramine did produce side effects.